Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04863560
Other study ID # PF-CRA-2073
Secondary ID 28638320/LO/1036
Status Recruiting
Phase
First received
Last updated
Start date October 1, 2020
Est. completion date November 30, 2022

Study information

Verified date April 2021
Source Northumbria University
Contact Samuel Stuart, PhD
Phone 01912233343
Email sam.stuart@northumbria.ac.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Lay Summary: Walking problems, such as slow and short steps, are very common in Parkinson's disease and lead to increased falls risk, as well as reduced mobility and quality of life. Walking issues are difficult to treat as medication interventions do not restore walking ability in people with Parkinson's, therefore physiotherapy approaches are used to help improve walking. Various physiotherapy strategies have been used, such as internal (thinking about bigger steps) or external prompts. External prompts include auditory (a metronome beat to step in time to), visual (lines to step over on the floor) and tactile (metronome-like vibration to step with) prompts that are very commonly used to improve walking in Parkinson's. However, the reason why walking improves in people with Parkinson's with these physiotherapy strategies is unknown, which has led to not all patients benefiting and only short-term walking improvements being seen. The main issues are that it is unclear if these various internal or external prompt strategies are effective with the progression of Parkinson's disease, and it is unknown which type of strategy is most effective at different disease stages or with more severe walking impairment, such as freezing (the inability to progress walking for short periods despite wanting to do so). Being able to use specific brain regions to pay attention to different internal or external prompts has been suggested to be the reason why people with Parkinson's can overcome their walking problems, but this has not been tested. Therefore, this study will use state-of-the-art digital technology to measure walking and brain activity changes with different internal and external prompts. The investigators think that the walking improvement with different prompt strategies relies on the ability to activate specific brain regions, and that brain region activity in response to internal or external prompts will change at different stages of Parkinson's disease. Ultimately, understanding the reasons why people benefit from these physiotherapy strategies and who benefits most from specific strategies will enable clinicians to provide more timely and efficient treatment for people with Parkinson's, and to develop more effective strategies to further improve walking.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date November 30, 2022
Est. primary completion date November 30, 2022
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - Clinical diagnosis of Parkinson's by a movement disorder specialist according to United Kingdom (UK) brain bank criteria - Hoehn & Yahr (H&Y) stage I-III - Aged >50 years - Able to walk and stand unaided - Adequate hearing (as evaluated by the whisper test; stand 2m behind subject and whisper a 2 syllable word, subject repeats word) and vision capabilities (as measured using a Snellen chart - 6/18-6/12). - Stable medication for the past 1 month and anticipated over a period of 6 months Exclusion Criteria: - Psychiatric co-morbidity (e.g., major depressive disorder as determined by Geriatric Depression Scale - short form (GDS-15); <10 [26]) - Clinical diagnosis of dementia or other severe cognitive impairment (Montreal cognitive assessment <21 [27]) - History of stroke, traumatic brain injury or other neurological disorders (other than PD, for the PD group) - Acute lower back or lower extremity pain, peripheral neuropathy, rheumatic and orthopaedic diseases - Unstable medical condition including cardio-vascular instability in the past 6 months - Unable to comply with the testing protocol or currently participating in another interfering research project - Interfering therapy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Auditory Cueing
Metronome beat to step in time with
Visual Cueing
Lines on the floor to step over
tactile Cueing
Vibration to step in time with (metronome like)

Locations

Country Name City State
United Kingdom Northumbria University Newcastle upon Tyne
United Kingdom Northumbria Healthcar NHS foundation trust North Shields
United States Oregon Health & Science University Portland Oregon

Sponsors (3)

Lead Sponsor Collaborator
Northumbria University Northumbria Healthcare NHS Foundation Trust, Parkinson's Foundation

Countries where clinical trial is conducted

United States,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in cortical oxygenated hemoglobin (HbO2) signal during walking Change in cortical oxygenated hemoglobin (HbO2) measured while walking with cueing, which will be quantified with a wireless functional near infrared spectroscopy (fNIRS) system immediately after intervention
Primary Change in cortical power spectral densities during walking Change in cortical power spectral densities of EEG signals from cortex with cueing, which will be quantified with a mobile electroencephalography (EEG) system immediately after intervention
Secondary Change in Stride Length (m) Change in stride length with cueing immediately after intervention
Secondary Change in Gait Speed (m/s) Change in speed of walking with cueing immediately after intervention
Secondary Change in Stride Time (s) Change in time taken to complete a stride when walking with cues immediately after intervention
Secondary Change in Gait Variability (SD) Change in variability (standard deviation; SD) of gait when walking with cues immediately after intervention
See also
  Status Clinical Trial Phase
Completed NCT05415774 - Combined Deep Brain Stimulation in Parkinson's Disease N/A
Recruiting NCT04691661 - Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease Phase 2
Active, not recruiting NCT05754086 - A Multidimensional Study on Articulation Deficits in Parkinsons Disease
Completed NCT04045925 - Feasibility Study of the Taïso Practice in Parkinson's Disease N/A
Recruiting NCT04194762 - PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation N/A
Completed NCT02705755 - TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05830253 - Free-living Monitoring of Parkinson's Disease Using Smart Objects
Recruiting NCT03272230 - Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System N/A
Recruiting NCT06139965 - Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
Completed NCT04580849 - Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease N/A
Completed NCT03980418 - Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam N/A
Completed NCT04477161 - Effect of Ketone Esters in Parkinson's Disease N/A
Recruiting NCT04788693 - Effects of Gait Rehabilitation With Motor Imagery in People With Parkinson's Disease N/A
Completed NCT04942392 - Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic N/A
Terminated NCT03446833 - LFP Beta aDBS Feasibility Study N/A
Completed NCT03497884 - Individualized Precise Localization of rTMS on Primary Motor Area N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT04997642 - Parkinson's Disease and Movement Disorders Clinical Database
Completed NCT04117737 - A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson N/A